|
LYEL Lyell Immunopharma Inc 1806952 |
| Balance Sheet |
|
Current Assets
|
450,045,000 |
|
Assets
|
619,215,000 |
|
Current Liabilities
|
33,512,000 |
|
Liabilities
|
88,518,000 |
|
Equity
|
530,697,000 |
|
Shares Out
|
23,307,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-115,152,000 |
|
Investing Cash Flow
|
68,919,000 |
| Market Analysis |
Market Cap
|
577,430,018 |
|
Price
|
24.78 |
|
BVPS
|
10.67 |
|
PB
|
0.05 |
|
EPS
|
-16.06 |
|
PS
|
2.49 |
|
FCF
|
-46,233,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LYEL documents filed with the SEC.
LYEL Filings
Clear
